• Profile
Close

A pilot study of the association of amino-terminal pro-B-type natriuretic peptide and severity of illness in pediatric septic shock

Pediatric Critical Care Medicine Feb 11, 2019

Melendez E, et al. - Via this prospective observational pilot study enrolling children 0–17 years old with a diagnosis of septic shock, researchers assessed if Emergency Department amino-terminal pro-B-type natriuretic peptide is associated with worse outcomes and severity of illness. In participants, each decile change increase in amino-terminal pro-B-type natriuretic peptide was noted to be associated with a change in ICU length of stay by 8.7%, hospital length of stay by 5.7%, organ dysfunction by 5.1%, a higher inotropic score at 12, 24, and 36 hours, and longer time requiring vasoactive agents. A significant correlation was identified between baseline amino-terminal pro-B-type natriuretic peptide and the Pediatric RISk of Mortality 3 score.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay